查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
過敏治療市場 - 按治療（抗過敏藥物、免疫療法）、類型（鼻炎、氣喘、皮膚、食物、眼睛）、給藥途徑、配銷通路、全球預測，2023 - 2032
市場調查報告書
商品編碼
1370622

過敏治療市場 - 按治療（抗過敏藥物、免疫療法）、類型（鼻炎、氣喘、皮膚、食物、眼睛）、給藥途徑、配銷通路、全球預測，2023 - 2032

Allergy Therapeutics Market - By Treatment (Anti-allergy drug, Immunotherapy ), Type (Rhinitis, Asthma, Skin, Food, Eye), Route of Administration, Distribution Channel, Global Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 215 Pages | 商品交期: 2-3個工作天內

價格

2023年至2032年，全球過敏治療市場的年複合成長率將達到6.6%。過敏（包括花粉熱和食物過敏等呼吸道過敏）盛行率的不斷上升，推動了對有效治療的需求。過敏診斷和免疫治療技術的進步改善了治療結果，推動了業務成長。

人們對過敏及其對健康影響的認知不斷增強，促使人們尋求醫療干涉，這對市場擴張來說是個好兆頭。此外，污染和氣候模式變化等環境因素導致過敏發生率升高，為業務成長開闢了新的空間。

此外，支持性醫療政策、合作措施和新型過敏療法的開發將進一步推動市場進步。賽諾菲公司於 2023 年 7 月宣布，已同意收購 Qunol，這是一家專門從事健康和保健行業的美國著名品牌。

市場根據治療類型、類型、給藥途徑、配銷通路和地區進行分類。

根據治療類型，到2032 年，免疫療法治療領域的年複合成長率將達到7%，這是由於人們越來越認知到免疫療法在解決過敏的根本原因、減輕症狀嚴重程度和為患者提供長期緩解方面的有效性，從而推動業務發展這種治療方式的成長。

根據類型，氣喘細分市場在2023 年至2032 年期間將錄得7.2% 的年複合成長率，原因包括氣喘盛行率增加、氣喘治療研究的擴大以及針對氣喘患者開發先進且更有針對性的治療方法，從而推動了氣喘市場的成長部分。

在整個分析期間，鼻內給藥途徑的年複合成長率為 6.8%。非侵入性治療的便利性和患者偏好、鼻內給藥在管理過敏症狀方面的有效性以及鼻內過敏療法的持續創新將推動該領域的成長。

從地區來看，在該地區過敏流行率不斷上升和醫療基礎設施不斷完善的推動下，亞太地區過敏治療行業在分析期內預計將以 7% 的年複合成長率成長。此外，患者意識的提高和對有效過敏治療的需求不斷成長將促進該地區的業務成長。

目錄

第 1 章：交付方法與範圍

  • 市場範圍和定義
  • 基本估計和計算
  • 預測參數
  • COVID-19 影響分析
  • 數據驗證
  • 資料來源
    • 基本的
    • 中學
      • 付費來源
      • 無償來源

第 2 章：執行摘要

第 3 章：過敏治療產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 過敏性疾病的盛行率不斷上升
      • 提高對過敏及其對健康影響的認知
      • 生物技術、基因組學和個人化醫療的不斷進步
      • 對新的和改進的治療方案的需求不斷增加
      • 增加醫療保健支出
    • 產業陷阱與挑戰
      • 不良反應和安全問題
      • 過敏原萃取物缺乏標準化
      • 由於缺乏認知、症狀輕微或獲得醫療保健的機會有限而導致未確診或診斷不足的病例
  • 成長潛力分析
  • COVID-19 影響分析
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章：過敏治療市場規模與預測：依治療類型

  • 主要動向：依治療類型
  • 抗過敏藥
    • 抗組織胺藥
    • 皮質類固醇
    • 減充血劑
    • 其他藥品
  • 免疫療法
    • 皮下免疫療法（SCIT）
    • 舌下免疫療法（SLIT）

第 6 章：過敏治療市場規模與預測：按類型

  • 主要動向：依類型
  • 眼睛過敏
  • 氣喘
  • 皮膚過敏
  • 食物過敏
  • 鼻炎
  • 其他過敏類型

第 7 章：過敏治療市場規模與預測：按給藥途徑

  • 主要動向：按給藥途徑
  • 口服
  • 吸入器
  • 鼻內
  • 其他給藥途徑

第 8 章：過敏治療市場規模與預測：按配銷通路

  • 主要動向：按配銷通路
  • 醫院藥房
  • 零售藥局
  • 其他分銷管道

第 9 章：過敏治療市場規模與預測：按地區

  • 主要動向：按地區
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 中東和非洲其他地區

第 10 章：公司簡介

  • Allergopharma
  • Danaher
  • AbbVie, Inc.
  • Allergy Therapeutics plc
  • Sanofi SA
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co., Inc.
Product Code: 6560

The global allergy therapeutics market will showcase a 6.6% CAGR from 2023 to 2032. The increasing prevalence of allergies, including respiratory allergies like hay fever and food allergies, drives demand for effective treatments. Advancements in allergy diagnostics and immunotherapy techniques have improved treatment outcomes, driving business growth.

A growing awareness of allergies and their impact on health prompts individuals to seek medical intervention will bode well for the market expansion. Moreover, environmental factors like pollution and changing climate patterns lead to a higher incidence of allergies, opening a new scope for business growth.

Additionally, supportive healthcare policies, collaborative initiatives and the development of novel allergy therapeutics will further drive the market progress. Sanofi SA announced in July 2023 that it had agreed to acquire Qunol, a prominent U.S.-based brand specializing in the health and wellness industry.

The market is segregated based on treatment type, type, route of administration, distribution channel, and region.

Based on treatment type, the immunotherapy treatment segment will exhibit a 7% CAGR through 2032, driven by the increasing recognition of immunotherapy's effectiveness in addressing the root causes of allergies, reducing symptom severity, and providing long-term relief to patients, thus driving business growth for this treatment modality.

Based on type, the asthma segment will record 7.2% CAGR during 2023-2032, driven by factors such as increasing prevalence of asthma, expanding research in asthma therapeutics, and the development of advanced and more targeted treatments for asthma patients, fueling growth in the segment.

The intranasal route of administration segment will depict a 6.8% CAGR throughout the analysis period. The convenience and patient preference for non-invasive treatments, the effectiveness of intranasal delivery in managing allergic symptoms, and continuous innovation in intranasal allergy therapies will drive growth in the segment.

Regionally, the Asia Pacific allergy therapeutics industry is estimated to grow at a 7% CAGR during the analysis timeline, driven by the region's increasing prevalence of allergies and rising healthcare infrastructure. Moreover, the expanding patient awareness and growing demand for effective allergy treatments will foster business growth in the region.

Table of Contents

Chapter 1 Delivery Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast parameters
  • 1.4 COVID-19 impact analysis
  • 1.5 Data validation
  • 1.6 Data Sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Allergy therapeutics industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Treatment type trends
    • 2.1.4 Type trends
    • 2.1.5 Route of administration trends
    • 2.1.6 Distribution channel trends

Chapter 3 Allergy Therapeutics Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of allergic conditions
      • 3.2.1.2 Increased awareness about allergies and their impact on health
      • 3.2.1.3 Rising advancements in biotechnology, genomics, and personalized medicine
      • 3.2.1.4 Increasing demand for new and improved treatment options
      • 3.2.1.5 Increasing healthcare expenditure
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Adverse effects and safety concerns
      • 3.2.2.2 Lack of standardization in allergen extracts
      • 3.2.2.3 Undiagnosed or underdiagnosed cases due to a lack of awareness, mild symptoms, or limited access to healthcare
  • 3.3 Growth potential analysis
    • 3.3.1 By treatment type
    • 3.3.2 By type
    • 3.3.3 By route of adminstration
    • 3.3.4 By distribution channel
  • 3.4 COVID- 19 impact analysis
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Company market share analysis, 2022
  • 4.4 Competitive analysis of major market players, 2022
  • 4.5 Competitive positioning matrix, 2022
  • 4.6 Strategic outlook matrix, 2022

Chapter 5 Allergy Therapeutics Market Size and Forecast, By Treatment type (USD Million)

  • 5.1 Key trends, by treatment type
  • 5.2 Anti-allergy drugs
    • 5.2.1 Antihistamines
    • 5.2.2 Corticosteroids
    • 5.2.3 Decongestants
    • 5.2.4 Other drugs
  • 5.3 Immunotherapy
    • 5.3.1 Sub-cutaneous immunotherapy (SCIT)
    • 5.3.2 Sub-lingual immunotherapy (SLIT)

Chapter 6 Allergy Therapeutics Market Size and Forecast, By Type (USD Million)

  • 6.1 Key trends, by type
  • 6.2 Eye allergy
  • 6.3 Asthma
  • 6.4 Skin allergy
  • 6.5 Food allergies
  • 6.6 Rhinitis
  • 6.7 Other allergy types

Chapter 7 Allergy Therapeutics Market Size and Forecast, By Route of administration (USD Million)

  • 7.1 Key trends, by route of administration
  • 7.2 Oral
  • 7.3 Inhalers
  • 7.4 Intranasal
  • 7.5 Other routes of administration

Chapter 8 Allergy Therapeutics Market Size and Forecast, By Distribution Channel (USD Million)

  • 8.1 Key trends, by distribution channel
  • 8.2 Hospital pharmacies
  • 8.3 Retail pharmacies
  • 8.4 Other distribution channels

Chapter 9 Allergy Therapeutics Market Size and Forecast, By Region (USD Million)

  • 9.1 Key trends, by region
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 Middle East & Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

  • 10.1 Allergopharma
  • 10.2 Danaher
  • 10.3 AbbVie, Inc.
  • 10.4 Allergy Therapeutics plc
  • 10.5 Sanofi SA
  • 10.6 Pfizer, Inc.
  • 10.7 Teva Pharmaceutical Industries Ltd.
  • 10.8 GlaxoSmithKline plc
  • 10.9 F. Hoffmann-La Roche Ltd.
  • 10.10 Merck & Co., Inc.

Data Tables

  • TABLE 1. Product mapping
  • TABLE 2. Market revenue, by treatment type (2022)
  • TABLE 3. Market revenue, by type (2022)
  • TABLE 4. Market revenue, by route of administration (2022)
  • TABLE 5. Market share, by distribution channel (2022)
  • TABLE 6. Market share, by region (2022)
  • TABLE 7. Global allergy therapeutics market size, 2018-2022, (USD Million)
  • TABLE 8. Global allergy therapeutics market size, 2023-2032, (USD Million)
  • TABLE 9. Global allergy therapeutics market size, by region, 2018-2022 (USD Million)
  • TABLE 10. Global allergy therapeutics market size, by region, 2023-2032 (USD Million)
  • TABLE 11. Global allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 12. Global allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 13. Global allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 14. Global allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 15. Global allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 16. Global allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 17. Global allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 18. Global allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 19. Industry impact forces
  • TABLE 20. Anti-allergy drugs market size, 2018-2022 (USD Million)
  • TABLE 21. Anti-allergy drugs market size, 2023-2032 (USD Million)
  • TABLE 22. Antihistamines market size, 2018-2022 (USD Million)
  • TABLE 23. Antihistamines market size, 2023-2032 (USD Million)
  • TABLE 24. Corticosteroids market size, 2018-2022 (USD Million)
  • TABLE 25. Corticosteroids market size, 2023-2032 (USD Million)
  • TABLE 26. Decongestants market size, 2018-2022 (USD Million)
  • TABLE 27. Decongestants market size, 2023-2032 (USD Million)
  • TABLE 28. Other drugs market size, 2018-2022 (USD Million)
  • TABLE 29. Other drugs market size, 2023-2032 (USD Million)
  • TABLE 30. immunotherapy market size, 2018-2022 (USD Million)
  • TABLE 31. immunotherapy market size, 2023-2032 (USD Million)
  • TABLE 32. Sub-cutaneous immunotherapy (SCIT) market size, 2018-2022 (USD Million)
  • TABLE 33. Sub-cutaneous immunotherapy (SCIT) market size, 2023-2032 (USD Million)
  • TABLE 34. Sub-lingual immunotherapy (SLIT) market size, 2018-2022 (USD Million)
  • TABLE 35. Sub-lingual immunotherapy (SLIT) market size, 2023-2032 (USD Million)
  • TABLE 36. Eye allergy market size, 2018-2022 (USD Million)
  • TABLE 37. Eye allergy market size, 2023-2032 (USD Million)
  • TABLE 38. Asthma market size, 2018-2022 (USD Million)
  • TABLE 39. Asthma market size, 2023-2032 (USD Million)
  • TABLE 40. Skin allergy market size, 2018-2022 (USD Million)
  • TABLE 41. Skin allergy market size, 2023-2032 (USD Million)
  • TABLE 42. Food allergies market size, 2018-2022 (USD Million)
  • TABLE 43. Food allergies market size, 2023-2032 (USD Million)
  • TABLE 44. Rhinitis market size, 2018-2022 (USD Million)
  • TABLE 45. Rhinitis market size, 2023-2032 (USD Million)
  • TABLE 46. Other allergy types market size, 2018-2022 (USD Million)
  • TABLE 47. Other allergy types market size, 2023-2032 (USD Million)
  • TABLE 48. Oral market size, 2018-2022 (USD Million)
  • TABLE 49. Oral market size, 2023-2032 (USD Million)
  • TABLE 50. Inhalers market size, 2018-2022 (USD Million)
  • TABLE 51. Inhalers market size, 2023-2032 (USD Million)
  • TABLE 52. Intranasal market size, 2018-2022 (USD Million)
  • TABLE 53. Intranasal market size, 2023-2032 (USD Million)
  • TABLE 54. Other routes of administration market size, 2018-2022 (USD Million)
  • TABLE 55. Other routes of administration market size, 2023-2032 (USD Million)
  • TABLE 56. Hospital pharmacies market size, 2018-2022 (USD Million)
  • TABLE 57. Hospital pharmacies market size, 2023-2032 (USD Million)
  • TABLE 58. Retail pharmacies market size, 2018-2022 (USD Million)
  • TABLE 59. Retail pharmacies market size, 2023-2032 (USD Million)
  • TABLE 60. Other distribution channels market size, 2018-2022 (USD Million)
  • TABLE 61. Other distribution channels market size, 2023-2032 (USD Million)
  • TABLE 62. North America allergy therapeutics market size, by country, 2018-2022 (USD Million)
  • TABLE 63. North America allergy therapeutics market size, by country, 2023-2032 (USD Million)
  • TABLE 64. North America allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 65. North America allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 66. North America allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 67. North America allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 68. North America allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 69. North America allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 70. North America allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 71. North America allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 72. North America allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 73. North America allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 74. North America allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 75. North America allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 76. U.S. allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 77. U.S. allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 78. U.S. allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 79. U.S. allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 80. U.S. allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 81. U.S. allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 82. U.S. allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 83. U.S. allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 84. U.S. allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 85. U.S. allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 86. U.S. allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 87. U.S. allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 88. Canada allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 89. Canada allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 90. Canada allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 91. Canada allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 92. Canada allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 93. Canada allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 94. Canada allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 95. Canada allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 96. Canada allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 97. Canada allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 98. Canada allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 99. Canada allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 100. Europe allergy therapeutics market size, by country, 2018-2022 (USD Million)
  • TABLE 101. Europe allergy therapeutics market size, by country, 2023-2032 (USD Million)
  • TABLE 102. Europe allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 103. Europe allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 104. Europe allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 105. Europe allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 106. Europe allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 107. Europe allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 108. Europe allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 109. Europe allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 110. Europe allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 111. Europe allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 112. Europe allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 113. Europe allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 114. Germany allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 115. Germany allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 116. Germany allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 117. Germany allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 118. Germany allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 119. Germany allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 120. Germany allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 121. Germany allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 122. Germany allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 123. Germany allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 124. Germany allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 125. Germany allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 126. UK allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 127. UK allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 128. UK allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 129. UK allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 130. UK allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 131. UK allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 132. UK allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 133. UK allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 134. UK allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 135. UK allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 136. UK allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 137. UK allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 138. France allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 139. France allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 140. France allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 141. France allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 142. France allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 143. France allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 144. France allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 145. France allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 146. France allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 147. France allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 148. France allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 149. France allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 150. Italy allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 151. Italy allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 152. Italy allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 153. Italy allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 154. Italy allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 155. Italy allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 156. Italy allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 157. Italy allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 158. Italy allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 159. Italy allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 160. Italy allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 161. Italy allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 162. Spain allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 163. Spain allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 164. Spain allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 165. Spain allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 166. Spain allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 167. Spain allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 168. Spain allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 169. Spain allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 170. Spain allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 171. Spain allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 172. Spain allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 173. Spain allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 174. Rest of Europe allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 175. Rest of Europe allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 176. Rest of Europe allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 177. Rest of Europe allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 178. Rest of Europe allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 179. Rest of Europe allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 180. Rest of Europe allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 181. Rest of Europe allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 182. Rest of Europe allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 183. Rest of Europe allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 184. Rest of Europe allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 185. Rest of Europe allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 186. Asia Pacific allergy therapeutics market size, by country, 2018-2022 (USD Million)
  • TABLE 187. Asia Pacific allergy therapeutics market size, by country, 2023-2032 (USD Million)
  • TABLE 188. Asia Pacific allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 189. Asia Pacific allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 190. Asia Pacific allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 191. Asia Pacific allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 192. Asia Pacific allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 193. Asia Pacific allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 194. Asia Pacific allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 195. Asia Pacific allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 196. Asia Pacific allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 197. Asia Pacific allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 198. Asia Pacific allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 199. Asia Pacific allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 200. Japan allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 201. Japan allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 202. Japan allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 203. Japan allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 204. Japan allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 205. Japan allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 206. Japan allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 207. Japan allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 208. Japan allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 209. Japan allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 210. Japan allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 211. Japan allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 212. China allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 213. China allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 214. China allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 215. China allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 216. China allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 217. China allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 218. China allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 219. China allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 220. China allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 221. China allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 222. China allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 223. China allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 224. India allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 225. India allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 226. India allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 227. India allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 228. India allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 229. India allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 230. India allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 231. India allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 232. India allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 233. India allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 234. India allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 235. India allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 236. Australia allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 237. Australia allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 238. Australia allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 239. Australia allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 240. Australia allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 241. Australia allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 242. Australia allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 243. Australia allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 244. Australia allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 245. Australia allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 246. Australia allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 247. Australia allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 248. Rest of Asia Pacific allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 249. Rest of Asia Pacific allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 250. Rest of Asia Pacific allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 251. Rest of Asia Pacific allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 252. Rest of Asia Pacific allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 253. Rest of Asia Pacific allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 254. Rest of Asia Pacific allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 255. Rest of Asia Pacific allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 256. Rest of Asia Pacific allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 257. Rest of Asia Pacific allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 258. Rest of Asia Pacific allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 259. Rest of Asia Pacific allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 260. Latin America allergy therapeutics market size, by country, 2018-2022 (USD Million)
  • TABLE 261. Latin America allergy therapeutics market size, by country, 2023-2032 (USD Million)
  • TABLE 262. Latin America allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 263. Latin America allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 264. Latin America allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 265. Latin America allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 266. Latin America allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 267. Latin America allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 268. Latin America allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 269. Latin America allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 270. Latin America allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 271. Latin America allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 272. Latin America allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 273. Latin America allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 274. Brazil allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 275. Brazil allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 276. Brazil allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 277. Brazil allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 278. Brazil allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 279. Brazil allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 280. Brazil allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 281. Brazil allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 282. Brazil allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 283. Brazil allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 284. Brazil allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 285. Brazil allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 286. Mexico allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 287. Mexico allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 288. Mexico allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 289. Mexico allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 290. Mexico allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 291. Mexico allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 292. Mexico allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 293. Mexico allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 294. Mexico allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 295. Mexico allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 296. Mexico allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 297. Mexico allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 298. Rest of Latin America allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 299. Rest of Latin America allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 300. Rest of Latin America allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 301. Rest of Latin America allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 302. Rest of Latin America allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 303. Rest of Latin America allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 304. Rest of Latin America allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 305. Rest of Latin America allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 306. Rest of Latin America allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 307. Rest of Latin America allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 308. Rest of Latin America allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 309. Rest of Latin America allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 310. Middle East & Africa allergy therapeutics market size, by country, 2018-2022 (USD Million)
  • TABLE 311. Middle East & Africa allergy therapeutics market size, by country, 2023-2032 (USD Million)
  • TABLE 312. Middle East & Africa allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 313. Middle East & Africa allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 314. Middle East & Africa allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 315. Middle East & Africa allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 316. Middle East & Africa allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 317. Middle East & Africa allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 318. Middle East & Africa allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 319. Middle East & Africa allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 320. Middle East & Africa allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 321. Middle East & Africa allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 322. Middle East & Africa allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 323. Middle East & Africa allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 324. South Africa allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 325. South Africa allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 326. South Africa allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 327. South Africa allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 328. South Africa allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 329. South Africa allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 330. South Africa allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 331. South Africa allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 332. South Africa allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 333. South Africa allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 334. South Africa allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 335. South Africa allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 336. Saudi Arabia allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 337. Saudi Arabia allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 338. Saudi Arabia allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 339. Saudi Arabia allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 340. Saudi Arabia allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 341. Saudi Arabia allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 342. Saudi Arabia allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 343. Saudi Arabia allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 344. Saudi Arabia allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 345. Saudi Arabia allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 346. Saudi Arabia allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 347. Saudi Arabia allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)
  • TABLE 348. Rest of Middle East & Africa allergy therapeutics market size, by treatment type, 2018-2022 (USD Million)
  • TABLE 349. Rest of Middle East & Africa allergy therapeutics market size, by treatment type, 2023-2032 (USD Million)
  • TABLE 350. Rest of Middle East & Africa allergy therapeutics market size, by anti-allergy drugs, 2018-2022 (USD Million)
  • TABLE 351. Rest of Middle East & Africa allergy therapeutics market size, by anti-allergy drugs, 2023-2032 (USD Million)
  • TABLE 352. Rest of Middle East & Africa allergy therapeutics market size, by immunotherapy, 2018-2022 (USD Million)
  • TABLE 353. Rest of Middle East & Africa allergy therapeutics market size, by immunotherapy, 2023-2032 (USD Million)
  • TABLE 354. Rest of Middle East & Africa allergy therapeutics market size, by type, 2018-2022 (USD Million)
  • TABLE 355. Rest of Middle East & Africa allergy therapeutics market size, by type, 2023-2032 (USD Million)
  • TABLE 356. Rest of Middle East & Africa allergy therapeutics market size, by route of administration, 2018-2022 (USD Million)
  • TABLE 357. Rest of Middle East & Africa allergy therapeutics market size, by route of administration, 2023-2032 (USD Million)
  • TABLE 358. Rest of Middle East & Africa allergy therapeutics market size, by distribution channel, 2018-2022 (USD Million)
  • TABLE 359. Rest of Middle East & Africa allergy therapeutics market size, by distribution channel, 2023-2032 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Top-down approach
  • FIG. 3 Market estimation and forecast
  • FIG. 4 Market forecasting methodology
  • FIG. 5 Breakdown of primary participants
  • FIG. 6 Allergy therapeutics industry, 360 degree synopsis, 2018 - 2032
  • FIG. 7 Industry landscape, 2018-2032 (USD Million)
  • FIG. 8 Growth potential analysis, by treatment type
  • FIG. 9 Growth potential analysis, by type
  • FIG. 10 Growth potential analysis, by route of administration
  • FIG. 11 Growth potential analysis, by distribution channel
  • FIG. 12 Porter's analysis
  • FIG. 13 PESTEL analysis
  • FIG. 14 Company matrix analysis, 2022
  • FIG. 15 Strategy dashboard, 2022